Recruiting
Phase 2

Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma

Sponsor:

Harry H Yoon

Code:

NCT04069273

Conditions

Gastric Cancer

GastroEsophageal Cancer

Adenocarcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pembrolizumab Monotherapy

Ramucirumab

Paclitaxel

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information